Intraoperative Terlipressin Therapy Reduces the Incidence of Postoperative Acute Kidney Injury After Living Donor Liver Transplantation

These results suggested that intraoperative terlipressin therapy is associated with significant reductions in the risk of AKI in LDLT patients.